In addition, in vivo studies have demonstrated enhanced immune responses, including increased T‐cell activation, natural killer cell clonal expansion, and enhanced tumor antigen presentation with KIT inhibitors.52, 53, 54, 55. Here, KIT is linked to neoplasm.